CTOR (Citius Oncology) Accounts Payable: $8.88 Mil (As of Mar. 2026)


CTOR Citius Oncology Inc CTOR
10 GF Score
Price $0.65
! 2 Warning Signs
View Full Analysis

What is Citius Oncology Accounts Payable?

Citius Oncology CTOR -7.12% 10 Accounts Payable is $8.88 Mil as of Mar. 2026. GuruFocus rates CTOR with a GF Score™ of 10/100. The stock has 2 warning signs investors should review.

Citius Oncology's Accounts Payable for the quarter that ended in Mar. 2026 was $8.88 Mil.

Citius Oncology's quarterly Accounts Payable declined from Sep. 2025 ($13.24 Mil) to Dec. 2025 ($10.45 Mil) and declined from Dec. 2025 ($10.45 Mil) to Mar. 2026 ($8.88 Mil).

Citius Oncology's annual Accounts Payable increased from Sep. 2023 ($1.29 Mil) to Sep. 2024 ($3.71 Mil) and increased from Sep. 2024 ($3.71 Mil) to Sep. 2025 ($13.24 Mil).

Citius Oncology Accounts Payable Related Terms

Citius Oncology Accounts Payable Historical Data

* Premium members only.

The historical data trend for Citius Oncology's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citius Oncology Accounts Payable Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24 Sep25
Accounts Payable
0.09 1.29 3.71 13.24

Citius Oncology Quarterly Data
Sep22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.68 8.67 13.24 10.45 8.88
CTOR
10GF Score
Citius Oncology Inc CTOR
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Citius Oncology Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $8.88 Mil mean?
Citius Oncology (CTOR) has a Accounts Payable of $8.88 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Citius Oncology and its competitors.
Is Citius Oncology's Accounts Payable too high?
Citius Oncology's current Accounts Payable is $8.88 Mil. Overall, Citius Oncology has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Citius Oncology's Accounts Payable compare to INCR and TLPH?
Citius Oncology's Accounts Payable of $8.88 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Citius Oncology and its competitors. Citius Oncology's current Accounts Payable is $8.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citius Oncology stock overvalued right now?
Citius Oncology (CTOR) has a current Accounts Payable of $8.88 Mil. The current Accounts Payable is $8.88 Mil. Citius Oncology's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Citius Oncology (CTOR), the current Accounts Payable is $8.88 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Citius Oncology Business Description

Address 11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
10GF Score

Get the complete analysis for CTOR

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price